Search clinical trials for: Apalutamide
Total 108 results
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic NeoplasmsUnited States, Australia, France, Poland, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Romania, Japan, Canada, Denmark, Finland, Korea, Republic of, Netherlands, New Zealand, Russian Federation, Hungary, Austria, Sweden, Slovaki... and more
-
Kindai UniversityJanssen Pharmaceutical K.K.RecruitingMetastatic Castration-sensitive Prostate CancerJapan
-
Aragon Pharmaceuticals, Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom, Moldova, Republic of
-
Janssen Research & Development, LLCRecruitingHepatic ImpairmentUnited States
-
Edwin Posadas, MDEnviro Therapeutics, Inc.RecruitingCastration-resistant Prostate CancerUnited States
-
Janssen Research & Development, LLCWithdrawn
-
Zhujiang HospitalRecruitingHigh-Risk and Oligometastatic Prostate CancerChina
-
BayerCompletedNon-metastatic Castration-resistant Prostate CancerUnited States
-
BayerActive, not recruitingNon-metastatic Castration-resistant Prostate CancerUnited States
-
Chinese University of Hong KongJanssen, LPTerminated
-
Janssen Research & Development, LLCCompleted
-
Westfälische Wilhelms-Universität MünsterJanssen Pharmaceutica N.V., BelgiumRecruitingProstatic NeoplasmsAustria, Germany
-
Institut Paoli-CalmettesJanssen-Cilag Ltd.UnknownLow Risk Prostate CancerFrance
-
Singapore General HospitalCompletedCancer of the ProstateSingapore
-
Janssen Research & Development, LLCActive, not recruiting
-
Aragon Pharmaceuticals, Inc.No longer availableProstatic NeoplasmsColombia, Brazil, Mexico
-
Universitaire Ziekenhuizen KU LeuvenUnknownProstate Cancer | Neoadjuvant Therapy | Prostatectomy | Androgen AntagonistsBelgium
-
Kangpu Biopharmaceuticals, Ltd.CompletedCastration-Resistant Prostate CancerUnited States
-
BayerActive, not recruiting
-
Janssen-Cilag Ltd.RecruitingMetastatic Hormone-sensitive Prostate CancerFrance, Germany, Spain, Greece, Austria, United Kingdom
-
CCTU- Cancer ThemeJanssen-Cilag Ltd.Completed
-
Azienda Ospedaliero-Universitaria CareggiNot yet recruitingOligometastatic Hormone Sensitive Prostate CancerItaly
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
BayerCompletedNon-metastatic Prostate Cancer | Non-metastatic Castration-resistant Prostate CancerUnited States
-
Janssen Pharmaceutical K.K.Completed
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge; Janssen-Cilag Ltd.Recruiting
-
University of AthensWithdrawnProstatic Neoplasms, Castration-Resistant
-
Janssen Pharmaceutica N.V., BelgiumRecruitingProstatic NeoplasmsBelgium, United States, Italy, Poland, Brazil, Denmark, Germany, Hungary, Mexico, Portugal, Russian Federation, Spain, Sweden, Turkey, Czechia, Finland, Austria, Australia, Lebanon, Slovakia, Jordan
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic NeoplasmsUnited States, France, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Israel, Mexico, Malaysia, Romania, Turkey, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Argentina, Sweden, Czechia
-
PfizerAstellas Pharma IncActive, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteDendreonRecruitingProstate Cancer | Metastatic Prostate CancerUnited States
-
Rahul AggarwalJanssen Scientific Affairs, LLCActive, not recruitingProstate Cancer | Small Cell Carcinoma | Small Cell Neuroendocrine CarcinomaUnited States
-
University of California, San FranciscoJanssen PharmaceuticalsActive, not recruitingCastration-Resistant Prostate Carcinoma | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of TestosteroneUnited States
-
PfizerAstellas Pharma IncActive, not recruitingProstatic NeoplasmsUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCNot yet recruitingProstate Cancer | Prostatectomy | Androgen Axis SuppressionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage IIB Prostate Cancer AJCC v8United States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Xian-Janssen Pharmaceutical Ltd.Not yet recruitingProstate Cancer | Biochemical Recurrence | High RiskChina
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCRecruitingMetastatic Castrate-sensitive Prostate CancerUnited States, France, Mexico, Germany, Australia, Brazil, Canada, China, Poland
-
University of WashingtonNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCTerminatedProstate AdenocarcinomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
Qilu Hospital of Shandong UniversityRecruiting
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
University of CincinnatiJanssen, LPRecruitingProstate CancerUnited States
-
National Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8United States
-
Janssen Research & Development, LLCActive, not recruiting
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstate CancerUnited States, France, Poland, Ukraine, United Kingdom, China, Spain, Argentina, Israel, Mexico, Romania, Turkey, Korea, Republic of, Japan, Sweden, Canada, Russian Federation, Brazil, Germany, Hungary, Czechia, Australia
-
Zhujiang HospitalRecruitingProstate Cancer With ≤10 Bone MetastasesChina
-
National Cancer Institute (NCI)Not yet recruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | Recurrent Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States